CARLOS
OCHOA SANGRADOR
Researcher in the period 2019-2022
University Hospital Heidelberg
Heidelberg, AlemaniaPublications in collaboration with researchers from University Hospital Heidelberg (1)
2022
-
Efficacy and safety of empagliflozin in glycogen storage disease type Ib: Data from an international questionnaire
Genetics in Medicine, Vol. 24, Núm. 8, pp. 1781-1788